Palomar Medical Tech (PMTI) Reports Mixed Q4 Results

Palomar Medical Tech (NASDAQ: PMTI) reported Q4 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $23 million versus the consensus estimate of $26.03 million.

For earnings history and earnings-related data on Palomar Medical Tech (PMTI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Reading (RDI) Tops Q2 EPS by 4c